Search results for "Atrial fibrillation"
Use of warfarin down, DOACs up in commercially insured patients with cirrhosis, nonvalvular afib
While more than half of eligible patients with cirrhosis and concurrent nonvalvular atrial fibrillation did not receive anticoagulation between 2012 and 2019, use of direct oral anticoagulants (DOACs) increased substantially during that time, a recent study found.
https://immattersacp.org/weekly/archives/2023/01/17/4.htm
17 Jan 2023
Apixaban associated with lower risk of GI bleeding compared to other DOACs
Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
https://immattersacp.org/weekly/archives/2022/11/01/1.htm
1 Nov 2022
Apixaban safer, more effective than rivaroxaban for afib with heart disease, study finds
Apixaban was associated with a lower rate of ischemic stroke or systemic embolism and a lower rate of bleeding in a propensity-matched cohort study of commercially insured patients with atrial fibrillation (AF) and valvular heart disease.
https://immattersacp.org/weekly/archives/2022/10/18/2.htm
18 Oct 2022
MKSAP Quiz: Elevated INR found on routine monitoring
A 75-year-old man is evaluated for an elevated INR found on routine monitoring. He is otherwise well and has no evidence of bleeding. Following lab studies and stopping warfarin, what is the most appropriate additional management?
https://immattersacp.org/weekly/archives/2022/09/27/3.htm
27 Sep 2022
New studies analyze risk factors, treatments for afib
One study found that early rhythm control was better than rate control for low-risk patients, another found that age at menarche and menopause was associated with afib risk, and another indicated that women's lower risk for afib is due to their smaller body size compared with men.
https://immattersacp.org/weekly/archives/2022/09/06/1.htm
6 Sep 2022
Risks and benefits of procedure versus medication in afib vary by individual
A modeling study found that left atrial appendage occlusion could be an alternative to oral anticoagulants in patients at high bleeding risk but that the combination of risks for stroke and bleeding should be considered on an individual basis.
https://immattersacp.org/weekly/archives/2022/08/16/4.htm
16 Aug 2022
Social isolation during pandemic may have raised CV event risk, AHA says
A new scientific statement from the American Heart Association (AHA) reported research on social isolation published through July 2021 to examine the relationship between social isolation and cardiovascular and brain health.
https://immattersacp.org/weekly/archives/2022/08/09/2.htm
9 Aug 2022
Diltiazem may increase bleeding risk when coadministered with DOACs in afib
A study of patients with atrial fibrillation in one U.S. health system found a 56% higher risk for bleeding-related hospitalization associated with concomitant use of diltiazem and a direct-acting oral anticoagulant (DOAC) versus a DOAC alone.
https://immattersacp.org/weekly/archives/2022/07/12/5.htm
12 Jul 2022
Review suggests optimal dose of omega-3 fatty acids for reducing blood pressure
The optimal intake for both systolic and diastolic blood pressure reduction is 2 to 3 g/d, according to a dose-response meta-analysis of 71 randomized controlled trials, although an editorial said omega-3s “are still not fully ready for prime time.”
https://immattersacp.org/weekly/archives/2022/06/07/2.htm
7 Jun 2022
MKSAP Quiz: Abrupt-onset palpitations
A 42-year-old woman is evaluated in the emergency department for abrupt-onset palpitations. For the past year, she has been having similar episodes with increasing frequency. Following a physical exam and ECG, what is the most likely rhythm diagnosis?
https://immattersacp.org/archives/2022/06/mksap-quiz-abrupt-onset-palpitations.htm
1 Jun 2022